Skip to content

Richard A. Heyman, Director at Oric Pharmaceuticals, sold ORIC on Oct 1, 2026

Data as of Oct 16

▼ SELL$45.2K3,500 shares at $12.91Richard A. Heyman DirectorORIC Oric Pharmaceuticals, Inc.
Watch ORIC
Traded
Oct 1, 2026
Disclosed
Oct 2, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Richard A. Heyman, Director at Oric Pharmaceuticals, sold ORIC on Oct 1, 2026TRADEDDISCLOSED
ORICSimilar stocks (S&P 500 (SPY)), rebased to ORIC's price on the disclosure day
ORIC since disclosure
+1.2%
after the sale
Similar stocks (SPY) since disclosure
−0.8%
S&P 500 (SPY)

Change in closing price from Oct 2, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLRichard A. Heyman DirectorORIC Oric Pharmaceuticals, Inc.$41.3Kdisclosed Oct 2 · filed 1 day after the trade

See every trade on ORIC →